179 related articles for article (PubMed ID: 15960772)
1. Mental health policy and psychotropic drugs.
Frank RG; Conti RM; Goldman HH
Milbank Q; 2005; 83(2):271-98. PubMed ID: 15960772
[TBL] [Abstract][Full Text] [Related]
2. Dual eligibles with mental disorders and Medicare part D: how are they faring?
Donohue JM; Huskamp HA; Zuvekas SH
Health Aff (Millwood); 2009; 28(3):746-59. PubMed ID: 19414883
[TBL] [Abstract][Full Text] [Related]
3. Managing psychotropic drug costs: will formularies work?
Huskamp HA
Health Aff (Millwood); 2003; 22(5):84-96. PubMed ID: 14515884
[TBL] [Abstract][Full Text] [Related]
4. Improving psychiatric drug benefit management: IV. Experiences of a pharmacy advisory committee.
Gottlieb D; Dubin WR; Ning A; Gardiner GC
Psychiatr Serv; 2004 Nov; 55(11):1210-2. PubMed ID: 15534007
[No Abstract] [Full Text] [Related]
5. Trends in mental health cost growth: an expanded role for management?
Frank RG; Goldman HH; McGuire TG
Health Aff (Millwood); 2009; 28(3):649-59. PubMed ID: 19414870
[TBL] [Abstract][Full Text] [Related]
6. Implications of Part D for mentally ill dual eligibles: a challenge for Medicare.
Morden NE; Garrison LP
Health Aff (Millwood); 2006; 25(2):491-500. PubMed ID: 16522603
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceuticals & psychotropic drugs.
Health Aff (Millwood); 2009; 28(3):723. PubMed ID: 19414880
[No Abstract] [Full Text] [Related]
8. Use and cost of psychotropic drugs among recipients with autism in a state Medicaid fee-for-service programme.
Khanna R; Jariwala K; West-Strum D
J Intellect Disabil Res; 2013 Feb; 57(2):161-71. PubMed ID: 22471524
[TBL] [Abstract][Full Text] [Related]
9. Increases in Medicare prescription drug plan costs attributable to psychotropic medications.
Zivin K; McCammon RJ; Davis MM; Halasyamani LK; Kales HC
Am J Geriatr Psychiatry; 2008 Aug; 16(8):674-85. PubMed ID: 18669946
[TBL] [Abstract][Full Text] [Related]
10. Comparative prevalence of psychotropic medications among youths enrolled in the SCHIP and privately insured youths.
Safer DJ; Zito JM; Gardner JF
Psychiatr Serv; 2004 Sep; 55(9):1049-51. PubMed ID: 15345766
[TBL] [Abstract][Full Text] [Related]
11. Improving mental health treatments through comparative effectiveness research.
Wang PS; Ulbricht CM; Schoenbaum M
Health Aff (Millwood); 2009; 28(3):783-91. PubMed ID: 19414887
[TBL] [Abstract][Full Text] [Related]
12. Economic grand rounds: the economics of the new medicare drug benefit: implications for people with mental illnesses.
Donohue JM
Psychiatr Serv; 2005 Jun; 56(6):645-7. PubMed ID: 15939937
[No Abstract] [Full Text] [Related]
13. Medicaid policy changes in mental health care and their effect on mental health outcomes.
Cuellar AE; Markowitz S
Health Econ Policy Law; 2007 Jan; 2(Pt 1):23-49. PubMed ID: 18634670
[TBL] [Abstract][Full Text] [Related]
14. Medicaid expenditures on psychotropic medications for children in the child welfare system.
Raghavan R; Brown DS; Thompson H; Ettner SL; Clements LM; Key W
J Child Adolesc Psychopharmacol; 2012 Jun; 22(3):182-9. PubMed ID: 22537361
[TBL] [Abstract][Full Text] [Related]
15. Coverage and prior authorization of psychotropic drugs under Medicare Part D.
Huskamp HA; Stevenson DG; Donohue JM; Newhouse JP; Keating NL
Psychiatr Serv; 2007 Mar; 58(3):308-10. PubMed ID: 17325102
[TBL] [Abstract][Full Text] [Related]
16. Datapoints: psychotropic medication costs among youth with private insurance in 1998.
Stein BD; Sturm R; Kapur K; Ringel J
Psychiatr Serv; 2001 Feb; 52(2):152. PubMed ID: 11157108
[No Abstract] [Full Text] [Related]
17. Medicaid prescription drug coverage: state efforts to control costs.
Gencarelli DM
NHPF Issue Brief; 2003 May; (790):1-17. PubMed ID: 12751504
[TBL] [Abstract][Full Text] [Related]
18. Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia.
Soumerai SB; McLaughlin TJ; Ross-Degnan D; Casteris CS; Bollini P
N Engl J Med; 1994 Sep; 331(10):650-5. PubMed ID: 8052275
[TBL] [Abstract][Full Text] [Related]
19. Mental health in the Medicare Part D drug benefit: a new regulatory model?
Donohue J
Health Aff (Millwood); 2006; 25(3):707-19. PubMed ID: 16684735
[TBL] [Abstract][Full Text] [Related]
20. Medication use and spending trends among children with ADHD in Florida's Medicaid program, 1996-2005.
Fullerton CA; Epstein AM; Frank RG; Normand SL; Fu CX; McGuire TG
Psychiatr Serv; 2012 Feb; 63(2):115-21. PubMed ID: 22302327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
